Ra Capital Management, L.P. Aerovate Therapeutics, Inc. Put Options Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVTE
# of Institutions
83Shares Held
30.7MCall Options Held
186KPut Options Held
269K-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$9.32 Million0.81% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$5.56 Million0.97% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.46 Million0.79% of portfolio
-
Braidwell LP Stamford, CT1.44MShares$3.57 Million0.21% of portfolio
-
Logos Global Management LP San Francisco, CA1.4MShares$3.47 Million0.49% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $60.6M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...